Thyroid hormone receptor and liver X receptor competitively up-regulate human selective Alzheimer's disease indicator-1 gene expression at the transcriptional levels

Biochemical and Biophysical Research Communications

Volumn 432, Issue 3, 2013, Pages 513-518

  Ishida, Emi ^a   Hashimoto, Koshi ^a   Okada, Shuichi ^a   Satoh, Tetsurou ^a   Yamada, Masanobu ^a   Mori, Masatomo ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Human Seladin 1; Liver X receptor; Thyroid hormone receptor

Indexed keywords

LIVER X RECEPTOR ALPHA; N (2,2,2 TRIFLUOROETHYL) N [4 (2,2,2 TRIFLUORO 1 HYDROXY 1 TRIFLUOROMETHYLETHYL)PHENYL]BENZENESULFONAMIDE; RETINOID X RECEPTOR; THYROID HORMONE RECEPTOR;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CHROMATIN IMMUNOPRECIPITATION; GENE; GENE EXPRESSION; GENE MUTATION; GENETIC REGULATION; HUMAN; HUMAN CELL; LIPID METABOLISM; NONHUMAN; PRIORITY JOURNAL; SELADIN 1 GENE; THYROID FUNCTION;

ALZHEIMER DISEASE; BASE SEQUENCE; BINDING, COMPETITIVE; CELL LINE, TUMOR; CONSENSUS SEQUENCE; GENE EXPRESSION REGULATION; HUMANS; HYDROCARBONS, FLUORINATED; NERVE TISSUE PROTEINS; ORPHAN NUCLEAR RECEPTORS; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; RESPONSE ELEMENTS; SULFONAMIDES; THYROID HORMONE RECEPTORS BETA; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 84874953844     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.02.023     Document Type: Article

References (29)

1. Brookmeyer R., Johnson E., Ziegler-Graham K., Arrighi H.M. Forecasting the global burden of Alzheimer's disease. Alzheimer's Dement 2007, 3:186-191.
2. Blennow K., de Leon M.J., Zetterberg H. Alzheimer's disease. Lancet 2006, 368:387-403.
3. Nunez J., Celi F.S., Ng L., Forrest D. Multigenic control of thyroid hormone functions in the nervous system. Mol. Cell. Endocrinol. 2008, 287:1-12.
4. Davis J.D., Stern R.A., Flashman L.A. Cognitive and neuropsychiatric aspects of subclinical hypothyroidism: significance in the elderly. Curr. Psychiatry. Rep. 2003, 5:384-390.
5. Hashimoto K., Curty F.H., Borges P.P., Lee C.E., Abel E.D., Elmquist J.K., Cohen R.N., Wondisford F.E. An unliganded thyroid hormone receptor causes severe neurological dysfunction. Proc. Natl. Acad. Sci. USA 2001, 98:3998-4003.
6. de Jong F.J., den Heijer T., Visser T.J., de Rijke Y.B., Drexhage H.A., Hofman A., Breteler M.M. Thyroid hormones, dementia, and atrophy of the medial temporal lobe. J. Clin. Endocrinol. Metab. 2006, 91:2569-2573.
7. Kalmijn S., Mehta K.M., Pols H.A., Hofman A., Drexhage H.A., Breteler M.M. Subclinical hyperthyroidism and the risk of dementia. The rotterdam study. Clin. Endocrinol. (Oxf.) 2000, 53:733-737.
8. Fu A.L., Zhou C.Y., Chen X. Thyroid hormone prevents cognitive deficit in a mouse model of Alzheimer's disease. Neuropharmacology 2010, 58:722-729.
9. Di Paolo G., Kim T.W. Linking lipids to Alzheimer's disease: cholesterol and beyond. Nat. Rev. Neurosci. 2011, 12:284-296.
10. Martin M., Dotti C.G., Ledesma M.D. Brain cholesterol in normal and pathological aging. Biochim. Biophys. Acta 2010, 1801:934-944.
11. Apfel R., Benbrook D., Lernhardt E., Ortiz M.A., Salbert G., Pfahl M. A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily. Mol. Cell. Biol. 1994, 14:7025-7035.
12. Stulnig T.M., Steffensen K.R., Gao H., Reimers M., Dahlman-Wright K., Schuster G.U., Gustafsson J.A. Novel roles of liver X receptors exposed by gene expression profiling in liver and adipose tissue. Mol. Pharmacol. 2002, 62:1299-1305.
13. Koldamova R.P., Lefterov I.M., Staufenbiel M., Wolfe D., Huang S., Glorioso J.C., Walter M., Roth M.G., Lazo J.S. The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer's disease. J. Biol. Chem. 2005, 280:4079-4088.
14. Riddell D.R., Zhou H., Comery T.A., Kouranova E., Lo C.F., Warwick H.K., Ring R.H., Kirksey Y., Aschmies S., Xu J., Kubek K., Hirst W.D., Gonzales C., Chen Y., Murphy E., Leonard S., Vasylyev D., Oganesian A., Martone R.L., Pangalos M.N., Reinhart P.H., Jacobsen J.S. The LXR agonist TO901317 selectively lowers hippocampal Abeta42 and improves memory in the Tg2576 mouse model of Alzheimer's disease. Mol. Cell. Neurosci. 2007, 34:621-628.
15. Huuskonen J., Vishnu M., Pullinger C.R., Fielding P.E., Fielding C.J. Regulation of ATP-binding cassette transporter A1 transcription by thyroid hormone receptor. Biochemistry 2004, 43:1626-1632.
16. Hashimoto K., Cohen R.N., Yamada M., Markan K.R., Monden T., Satoh T., Mori M., Wondisford F.E. Cross-talk between thyroid hormone receptor and liver X receptor regulatory pathways is revealed in a thyroid hormone resistance mouse model. J. Biol. Chem. 2006, 281:295-302.
17. Hashimoto K., Ishida E., Matsumoto S., Okada S., Yamada M., Satoh T., Monden T., Mori M. Carbohydrate response element binding protein gene expression is positively regulated by thyroid hormone. Endocrinology 2009, 150:3417-3424.
18. Greeve I., Hermans-Borgmeyer I., Brellinger C., Kasper D., Gomez-Isla T., Behl C., Levkau B., Nitsch R.M. The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stress. J. Neurosci. 2000, 20:7345-7352.
19. Waterham H.R., Koster J., Romeijn G.J., Hennekam R.C., Vreken P., Andersson H.C., FitzPatrick D.R., Kelley R.I., Wanders R.J. Mutations in the 3beta-hydroxysterol Delta24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis. Am. J. Hum. Genet. 2001, 69:685-694.
20. Cecchi C., Rosati F., Pensalfini A., Formigli L., Nosi D., Liguri G., Dichiara F., Morello M., Danza G., Pieraccini G., Peri A., Serio M., Stefani M. Seladin-1/DHCR24 protects neuroblastoma cells against Abeta toxicity by increasing membrane cholesterol content. J. Cell. Mol. Med. 2008, 12:1990-2002.
21. Kuehnle K., Crameri A., Kälin R.E., Luciani P., Benvenuti S., Peri A., Ratti F., Rodolfo M., Kulic L., Heppner F.L., Nitsch R.M., Mohajeri M.H. Prosurvival effect of DHCR24/Seladin-1 in acute and chronic responses to oxidative stress. Mol. Cell. Biol. 2008, 28:539-550.
22. Luciani P., Deledda C., Rosati F., Benvenuti S., Cellai I., Dichiara F., Morello M., Vannelli G.B., Danza G., Serio M., Peri A. Seladin-1 is a fundamental mediator of the neuroprotective effects of estrogen in human neuroblast long-term cell cultures. Endocrinology 2008, 149:4256-4266.
23. Benvenuti S., Luciani P., Cellai I., Deledda C., Baglioni S., Saccardi R., Urbani S., Francini F., Squecco R., Giuliani C., Vannelli G.B., Serio M., Pinchera A., Peri A. Thyroid hormones promote cell differentiation and up-regulate the expression of the seladin-1 gene in in vitro models of human neuronal precursors. J. Endocrinol. 2008, 197:437-446.
24. Wang Y., Rogers P.M., Stayrook K.R., Su C., Varga G., Shen Q., Nagpal S., Burris T.P. The selective Alzheimer's disease indicator-1 gene (Seladin-1/DHCR24) is a liver X receptor target gene. Mol. Pharmacol. 2008, 74:1716-1721.
25. Ishida E., Hashimoto K., Okada S., Satoh T., Yamada M., Mori M. Crosstalk between thyroid hormone receptor and liver X receptor in the regulation of selective Alzheimer's disease indicator-1 gene expression. PLoS One 2013, 8:e54901.
26. Hashimoto K., Yamada M., Monden T., Satoh T., Wondisford F.E., Mori M. Thyrotropin-releasing hormone (TRH) specific interaction between amino terminus of P-Lim and CREB binding protein (CBP). Mol. Cell. Endocrinol. 2005, 229:11-20.
27. Matsumoto S., Hashimoto K., Yamada M., Satoh T., Hirato J., Mori M. Liver X receptor-alpha regulates proopiomelanocortin (POMC) gene transcription in the pituitary. Mol. Endocrinol. 2009, 23:47-60.
28. Wang D.P., Stroup D., Marrapodi M., Crestani M., Galli G., Chiang J.Y. Transcriptional regulation of the human cholesterol 7 alpha-hydroxylase gene (CYP7A) in HepG2 cells. J. Lipid Res. 1996, 37:1831-1841.
29. Menke J.G., Macnaul K.L., Hayes N.S., Baffic J., Chao Y.S., Elbrecht A., Kelly L.J., Lam M.H., Schmidt A., Sahoo S., Wang J., Wright S.D., Xin P., Zhou G., Moller D.E., Sparrow C.P. A novel liver X receptor agonist establishes species differences in the regulation of cholesterol 7alpha-hydroxylase CYP7a. Endocrinology 2002, 143:2548-2558.